Emily Cayssials received a grant from the Fondation Bergonié for her research project on the role of gamma-delta T cells in Chronic Myeloid leukemia.
The prize ceremony took place at the Hotel de Region, on November 28th.
Voir et revoir la vidéo préparée par le CNRS et diffusée lors de la cérémonie de remise de la Médaille d’Argent du CNRS à Julie Déchanet-Merville.
The CNRS silver medal honors researchers for the originality, quality and importance of their work recognized nationally and internationally. This year, Julie Déchanet-Merville is one of the 24 laureates. Congratulations boss!
Chaque année le CNRS récompense les femmes et les hommes qui ont le plus contribué au rayonnement, à l’avancée et à l’accompagnement de la recherche. Cette année Julie Déchanet-Merville est une des 24 lauréates et lauréats de la médaille d’argent du CNRS 2023 qui distingue des chercheuses et des chercheurs pour l’originalité, la qualité et l’importance de leurs travaux, reconnus sur le plan national et international. Félicitations !
The CNRS silver medal honors researchers for the originality, quality and importance of their work recognized nationally and internationally. This year, Julie Déchanet-Merville is one of the 24 laureates. Congratulations boss!
We are delighted to welcome Mathilde Pohin, who is a research scientist at the Kennedy Institute of Rheumatology in Oxford, UK. She works in the laboratory of Pr. Fiona Powrie on the mechanisms of inflammatory bowel disease patient’s resistance to therapy.
Here is the abstract of her presentation: The complex multifactorial nature of Inflammatory Bowel Disease (IBD) and heterogeneous clinical phenotypes restrains our ability to target biological therapies to those most likely to benefit. A roadblock to targeted therapy in IBD is patient stratification. To date patient stratification is limited to clinical symptoms and phenotype (Crohn’s Disease, Ulcerative Colitis) which shows only moderate differences in transcriptomic signatures and cellular composition. The use of unsupervised clustering of ‘omic and cellular signatures is now recognised as a promising option to overcome this challenge. We applied this approach in IBD by integrating bulk RNA-sequencing network-based discovery analysis with single cell transcriptomics and investigation of molecular pathology to identify and define distinct tissular responses termed ‘pathotypes’. Such pathotypes represent a new way to stratify patients based on distinct intestinal tissue ecologies which involve the remodelling of tissue resident stromal cell populations and the activation of innate and adaptive immune cell compartments. Our study demonstrates the feasibility of identifying pathotypes and their association with response to therapy. We are now building on this work to create an atlas of IBD pathotypes and perform mechanistic analyse to identify underlying pathophysiological mechanisms and identifying which biological therapies are most likely to benefit each pathotypes.
More informations about the award: https://www.frm.org/nos-publications/portraits-de-chercheurs/patrick-blanco
Page Facebook de l’événement: https://fb.me/e/fV45CFrh0
Le Département Sciences Biologiques et Médicales organise sa 1ère Journée Grand Public.
Le bâtiment BBS (Bordeaux Biologie Santé) vous ouvre ses portes : venez discuter avec les chercheurs, participer à des ateliers, découvrir les laboratoires de recherche.
See program here: https://sbm.u-bordeaux.fr/evenements/la-recherche-sur-la-biologie-et-les-maladies-du-vieillissement-bordeaux
Life expectancy is increasing, but ageing remains inevitable and is associated with several illnesses: cancers, cardiovascular diseases (heart attack, stroke, etc.), neurodegenerative diseases (Parkinson’s and Alzheimer’s diseases, etc.) metabolic diseases (obesity, type 2 diabetes, etc.), and infections (SARS-CoV-2, Sepsis, etc.)
In the hope of changing this situation, several research teams of the University of Bordeaux are trying to better understand the ageing process and the onset of associated co-morbidities. The objective is to slow down the effect of ageing and improve the quality of life of older people.
In this context, the Bordeaux research community working on the biology and diseases of aging is organizing a day of scientific presentations and discussions on November 14 in the amphitheater of the BBS building. The aim of the event is to exchange scientific knowledge, inform the scientific community about this research theme and stimulate interdisciplinary interaction.
Organizing committee: Hélène Amieva, Victor Appay, Thierry Couffinhal, Stéphanie Debette, Julie Dechanet Merville, Alain Pierre Gadeau, Catherine Helmer, Maël Lemoine, Vincent Planche, Isabelle Pellegrin, Hamid-Reza Rezvani, Claire Roubaud, Katie Sawaï, Pierre Soubeyran
The entire research department UMR CNRS 5164 – Immunoconcept celebrated the move to the new research building BBS. We took advantage of this celebration to specifically thank Vincent Pitard and Nathalie Schmitt for their immense contribution to make this move nice an smooth.
The “bureau des enquêtes” is organised by Cap Science Bordeaux together with the University of Bordeaux. The goal is for a scientist to disseminate to the general audience what are the main aims of his/her research and how do they reach their goal. The scientist has to bring three object that should be used by people stoping by the stand to guess what is the project the scientist is working on. Vanja Sisirak brought a hamburger toy, a box of matches and double helix of DNA. This initiated very nice and pleasant exchanges with the people. Try to guess on what is Vanja’s team project…
Several members of ImmunoConcEpT will attend the French Society of Immunology’s conference:
-Julie Déchanet-Merville is invited speaker and will chair a session
-Claire Liebler and Marc Scherlinger are invited speakers
RDV: September 26-29th, 2023 in STRASBOURG
All right reserved © immunoconcept.cnrs.fr 2023 by Nivo-Web